CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Résumé de cet Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Downie, J.
Right arrow Articles by Shea, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Downie, J.
Right arrow Articles by Shea, A.
Canadian Journal of Anesthesia 55:458-469 (2008)
© Canadian Anesthesiologists' Society, 2008

Special Article

Pre-mortem transplantation optimizing interventions: the legal status of consent

[Interventions pre-mortem pour optimiser la greffe d’organes : le statut légal du consentement]

Jocelyn Downie, SJD*, Chantelle Rajotte, BSc* and Alison Shea, MA LLB{dagger}

* From the Faculties of Law and Medicine, Dalhousie University, and the
{dagger} Regional Tissue Bank, QEII Health Sciences Centre, Halifax, Nova Scotia, Canada.

Address correspondence to: Jocelyn Downie, Faculty of Law, Dalhousie University, 6061 University Avenue, Halifax, Nova Scotia B3H 4H9, Canada. Phone: 902-494-6883; Fax: 902-494-6879; E-mail: jocelyn.downie{at}dal.ca

Purpose: The focus of this paper is on consent issues surrounding pre-mortem transplantation optimizing interventions. First, we explore the potential consequences of the different types of pre-mortem transplantation optimizing interventions that might be used, and we examine the current Canadian practice with respect to these interventions. We then analyze the status of consent to pre-mortem transplantation optimizing interventions under the current legal framework. Finally, we provide recommendations on how to improve the current legal framework.

Principal findings: In Canada, as in many countries in the world today, there is a shortage of organs available for transplantation. Canada’s deceased donor rate was 12.8 per million in 2005, a rate that has been stable over the past 12 years. At the end of 2005, the number of Canadians on waiting lists for an organ was 4,025 (125 out of every million Canadians). In total, 283 patients died in 2005 while waiting for new organs. To address the shortage of available organs, a number of changes have recently been made to organ donation practices and protocols. The use of pre-mortem transplantation optimizing interventions is a significant issue in organ donation, and it has become increasingly important to reflect on the use of such interventions, in light of these new practices. "Pre-mortem transplantation optimizing interventions" are interventions that are carried out on a patient, before his or her death, for the purpose of optimizing the chances of successful transplantation.

Conclusions: We argue that consent is legally required and must be express and competent patients have the legal authority to consent; but the law with respect to legal authority to consent on behalf of incompetent patients varies across the country. We come to the unsettling conclusion that the legality of pre-mortem transplantation optimizing interventions in many circumstances is at best questionable. We provide concrete recommendations (draft statutory text) on how to improve the current legal framework.

1 Dodek P. Mandatory reporting of ‘imminent’ death to identify organ donors: history, controversy and potential solutions. Can J Anesth 2003; 50: 955–60.[Abstract/Free Full Text]

2 Bell MD. Non-heart beating organ donation: old procurement strategy – new ethical problems. J Med Ethics 2003; 29: 176–81.[Abstract/Free Full Text]

3 Cook DJ, Giacomini M, Johnson N, Willms D. Life support in the intensive care unit: a qualitative investigation of technological purposes. Canadian Critical Trials Group. CMAJ 1999; 161: 1109–13.[Abstract/Free Full Text]

4 Browne A, Gillett G, Tweeddale M. The ethics of elective (non-therapeutic) ventilation. Bioethics 2000; 14: 42–57.[Medline]

5 Kluge EH. Elective, non-therapeutic ventilation: a reply to Browne et al. "The ethics of elective (non-therapeutic) ventilation". Bioethics 2000; 14: 240–7.[Medline]

6 Browne A, Gillett G, Tweeddale M. Elective ventilation: reply to Kluge. Bioethics 2000; 14: 248–53.[Medline]

7 Tregillus EV. Informed consent for trial of elective ventilation will not be forthcoming. BMJ 1995; 311: 1502.[Free Full Text]

8 Fabre J. Elective ventilation of potential organ donors. BMJ 1995; 311: 950.[Free Full Text]

9 Lewis J, Peltier J, Nelson H, et al. Development of the University of Wiscosin donation after cardiac death evaluation tool. Prog Transplant 2003; 13: 265–73.[Medline]

10 Peppin P. Informed consent. In: Downie J, Caulfield T, Flood CM (Eds). Canadian Health Law and Policy, 3rd ed. Markham: LexisNexis Canada Inc., 2007.

11 Picard EI, Robertson GB. Legal Liability of Doctors and Hospitals in Canada, 3rd ed. Scarborough: Carswell Publishing; 1996.

12 Sneiderman B, Irvine JC, Osbourne PH. Canadian Medical Law: An Introduction for Physicians, Nurses and Other Health Care Professionals, 3rd ed. Scarborough: Carswell Publishing; 2003.

13 Wildeman S, Downie J. Genetic and metabolic screening of newborns: must health care providers seek explicit parental consent? Health Law J 2001; 9: 61–111.[Medline]

14 Rozovsky LE. The Canadian Law of Consent to Treatment, 3rd ed. Markham: LexisNexis Canada Inc.; 2003.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the Canadian Anesthesiologists' Society.